ATE323776T1 - Retrovirale vektoren zur expression in embryonalen zellen - Google Patents

Retrovirale vektoren zur expression in embryonalen zellen

Info

Publication number
ATE323776T1
ATE323776T1 AT95944182T AT95944182T ATE323776T1 AT E323776 T1 ATE323776 T1 AT E323776T1 AT 95944182 T AT95944182 T AT 95944182T AT 95944182 T AT95944182 T AT 95944182T AT E323776 T1 ATE323776 T1 AT E323776T1
Authority
AT
Austria
Prior art keywords
vector
retroviral
expression
virus
retroviral vectors
Prior art date
Application number
AT95944182T
Other languages
English (en)
Inventor
Donald B Kohn
Pia M Challita
Original Assignee
Children S Hospital Los Angele
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Children S Hospital Los Angele filed Critical Children S Hospital Los Angele
Application granted granted Critical
Publication of ATE323776T1 publication Critical patent/ATE323776T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
    • C12N2740/11022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95944182T 1994-12-21 1995-12-19 Retrovirale vektoren zur expression in embryonalen zellen ATE323776T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/361,112 US5707865A (en) 1994-12-21 1994-12-21 Retroviral vectors for expression in embryonic cells

Publications (1)

Publication Number Publication Date
ATE323776T1 true ATE323776T1 (de) 2006-05-15

Family

ID=23420695

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95944182T ATE323776T1 (de) 1994-12-21 1995-12-19 Retrovirale vektoren zur expression in embryonalen zellen

Country Status (11)

Country Link
US (1) US5707865A (de)
EP (1) EP0801575B1 (de)
JP (1) JPH10510995A (de)
AT (1) ATE323776T1 (de)
AU (1) AU693317B2 (de)
CA (1) CA2208210A1 (de)
DE (1) DE69534948T2 (de)
DK (1) DK0801575T3 (de)
NZ (1) NZ300795A (de)
PT (1) PT801575E (de)
WO (1) WO1996019245A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5703796A (en) * 1995-05-10 1996-11-29 Introgene B.V. Improved retroviral vectors, especially suitable for gene th erapy
CA2222808A1 (en) * 1995-06-02 1996-12-05 Tadanori Yoshimatsu Cells producing recombinant retrovirus
US7129043B1 (en) 1998-10-22 2006-10-31 Duke University Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease
US6642038B1 (en) 1999-09-14 2003-11-04 Genzyme Glycobiology Research Institute, Inc. GlcNAc phosphotransferase of the lysosomal targeting pathway
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US7381813B2 (en) 2001-05-31 2008-06-03 Novartis Ag Nucleic acids encoding estrogen receptor ligand binding domain variants
US20030124652A1 (en) * 2001-12-21 2003-07-03 Novazyme Pharmaceuticals, Inc. Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells
US6905856B2 (en) * 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
US6800472B2 (en) * 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US20040009158A1 (en) * 2002-07-11 2004-01-15 Washington University Promotion of neovascularization using bone marrow-derived endothelial-progenitor cells
EP3188762A4 (de) 2014-07-31 2018-01-10 The Board of Regents of the University of Oklahoma Mutanten von säugetier rpe65 mit hoher isomerohydrolaseaktivität
CN110607394A (zh) * 2018-06-15 2019-12-24 云舟生物科技（广州）有限公司 莫洛尼鼠白血病病毒滴度检测试剂盒及滴度检测方法
WO2025059113A1 (en) 2023-09-12 2025-03-20 The Board Of Regents Of The University Of Oklahoma Treatments for enhancing immune response to clostridioides difficile infections

Also Published As

Publication number Publication date
CA2208210A1 (en) 1996-06-27
WO1996019245A1 (en) 1996-06-27
US5707865A (en) 1998-01-13
AU693317B2 (en) 1998-06-25
DE69534948D1 (de) 2006-05-24
JPH10510995A (ja) 1998-10-27
DE69534948T2 (de) 2006-11-16
EP0801575A4 (de) 2001-08-16
PT801575E (pt) 2006-08-31
AU4604696A (en) 1996-07-10
NZ300795A (en) 2001-08-31
DK0801575T3 (da) 2006-08-21
EP0801575B1 (de) 2006-04-19
EP0801575A1 (de) 1997-10-22

Similar Documents

Publication Publication Date Title
GB2331522A (en) Lentiviral vectors
DE69534948D1 (de) Retrovirale vektoren zur expression in embryonalen zellen
Wimmer et al. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b
GB2325003A (en) Rectroviral vectors
CY1107760T1 (el) Κυτταρα φακοϊικου εγκλεισμου
CA2324028A1 (en) Retroviral packaging cell line
CA2092195A1 (en) Retroviral packaging cell line
DE68927665D1 (de) Von synthetischer DNS abgeleitete rekombinante HIV-1-Antigene
ZA894137B (en) Expression of retrovirus gag protein eukaryotic cells
DE69636581D1 (de) Retrovirale Vektoren
JP2003514565A5 (de)
DK0781343T3 (da) Retrovirale vektorhybrider og anvendelsen deraf til gentransfer
WO1998053104A3 (en) Detection of retroviral subtypes based upon envelope specific sequences
WO1999061589A3 (en) Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
WO1998038325A3 (de) Retrovirale vektoren, verfahren zu ihrer herstellung und ihre verwendung zur genübertragung in cd4-positive zellen
WO2000001835A3 (en) Targeted integration into chromosomes using retroviral vectors
WO2002034929A3 (en) Expression vectors and uses thereof
CA2331440A1 (en) Amphotropic retrovirus packaging cell line, process for its production and use thereof
WO2000071737A3 (en) Improved retroviral production by inhibition of the enveloppe cell receptor
DE60210979D1 (de) Vektor zur phänotypischen charakterisierung von v3-sequenze aus dem gp120-protein von hiv-1
GB2333102A (en) Detection of retroviral subtypes based upon envelope specific sequence
IE891750L (en) Expression of retrovirus gag protein in eukaryotic cells

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0801575

Country of ref document: EP

REN Ceased due to non-payment of the annual fee